Matches in Nanopublications for { ?s ?p "[Aberrant methylation of FBN2 was present in 55% (6 of 11) of non-small cell lung cancer (NSCLC) cell lines, but it absent in small cell lung cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[Aberrant methylation of FBN2 was present in 55% (6 of 11) of non-small cell lung cancer (NSCLC) cell lines, but it absent in small cell lung cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP396094.RAV8LcrTqUdHZnFc4RXkW_o634zuVdLSL0qnAKcQMCCJg130_assertion description "[Aberrant methylation of FBN2 was present in 55% (6 of 11) of non-small cell lung cancer (NSCLC) cell lines, but it absent in small cell lung cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP396094.RAV8LcrTqUdHZnFc4RXkW_o634zuVdLSL0qnAKcQMCCJg130_provenance.
- NP499047.RAG4gHrvy1aFnXtItB_wsmZGOEV0u7KuoUuaz1Jv0h8Vw130_assertion description "[Aberrant methylation of FBN2 was present in 55% (6 of 11) of non-small cell lung cancer (NSCLC) cell lines, but it absent in small cell lung cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499047.RAG4gHrvy1aFnXtItB_wsmZGOEV0u7KuoUuaz1Jv0h8Vw130_provenance.